Published in ScientificWorldJournal on May 22, 2012
Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke (1999) 6.18
Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science (2004) 4.09
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A (2001) 3.80
Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke (2004) 3.53
A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab (1999) 3.25
Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology (2008) 3.04
Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. J Intern Med (2008) 2.55
Pathophysiology and therapy of experimental stroke. Cell Mol Neurobiol (2006) 2.21
Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res (2002) 2.04
A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J Neurosci (2006) 2.04
Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol (2001) 1.94
Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci (1996) 1.91
Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci U S A (2003) 1.88
Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem Biophys Res Commun (1998) 1.85
Animal models of focal and global cerebral ischemia. ILAR J (2003) 1.72
Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice. J Cereb Blood Flow Metab (2006) 1.68
Molecular biology of erythropoietin. Intern Med (2004) 1.66
Quantitative analysis of the olfactory pathway for drug delivery to the brain. Brain Res (1995) 1.65
Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr Res (1998) 1.60
The nasal route as a potential pathway for delivery of erythropoietin in the treatment of acute ischemic stroke in humans. ScientificWorldJournal (2009) 1.58
Delayed neuronal death in the rat hippocampus following transient forebrain ischemia. Acta Neuropathol (1984) 1.57
Fine structural nature of delayed neuronal death following ischemia in the gerbil hippocampus. Acta Neuropathol (1984) 1.55
Plasticity and remodeling of brain. J Neurol Sci (2007) 1.49
Treatment with nasal neuro-EPO improves the neurological, cognitive, and histological state in a gerbil model of focal ischemia. ScientificWorldJournal (2010) 1.45
Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. J Neuropathol Exp Neurol (2001) 1.41
Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics (2009) 1.36
The efficacy of erythropoietin and its analogues in animal stroke models: a meta-analysis. Stroke (2009) 1.29
Continuing postischemic neuronal death in CA1: influence of ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats. Stroke (1999) 1.29
A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury. Proc Natl Acad Sci U S A (2005) 1.24
Brain uptake of the glucagon-like peptide-1 antagonist exendin(9-39) after intranasal administration. J Pharmacol Exp Ther (2004) 1.23
Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin. J Cereb Blood Flow Metab (2001) 1.22
Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives. J Cereb Blood Flow Metab (2006) 1.21
Are the extracellular [correction of extracelluar] pathways a conduit for the delivery of therapeutics to the brain? Curr Pharm Des (2004) 1.19
Neuroprotective effect of darbepoetin alfa, a novel recombinant erythropoietic protein, in focal cerebral ischemia in rats. Stroke (2005) 1.18
Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia. Neurosci Lett (2005) 1.11
The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential. Biol Neonate (2001) 1.10
Experimental models for the investigation of brain ischemia. Cardiovasc Res (1998) 1.08
Diffusion-weighted magnetic resonance imaging of acute focal cerebral ischemia: comparison of signal intensity with changes in brain water and Na+,K(+)-ATPase activity. J Cereb Blood Flow Metab (1994) 1.07
Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor. J Neurotrauma (2010) 1.03
Advances in ischemic stroke treatment: neuroprotective and combination therapies. Expert Opin Emerg Drugs (2007) 1.03
Erythropoietin is a multifunctional tissue-protective cytokine. Curr Hematol Rep (2003) 1.02
Animal models of ischemic stroke: balancing experimental aims and animal care. Comp Med (2004) 1.01
Optimal neuroprotection by erythropoietin requires elevated expression of its receptor in neurons. Proc Natl Acad Sci U S A (2009) 0.99
Safety and efficacy of alteplase in the treatment of acute ischemic stroke. Vasc Health Risk Manag (2009) 0.98
Mechanisms underlying human motor system plasticity. Muscle Nerve (2001) 0.97
Carbamylated erythropoietin ameliorates the metabolic stress induced in vivo by severe chronic hypoxia. Proc Natl Acad Sci U S A (2006) 0.92
Erythropoietin prevents cognition impairment induced by transient brain ischemia in gerbils. Eur J Pharmacol (2002) 0.91
New technologies for drug delivery across the blood brain barrier. Curr Pharm Des (2004) 0.89
Effects of epoetin alfa on the central nervous system. Semin Oncol (2001) 0.87
Use of hydrogen for measurement of regional cerebral blood flow: problem of intercompartmental diffusion. Stroke (1977) 0.87
Carotid ligation in gerbils. Influence of age, sex, and gonads. Stroke (1977) 0.87
Treating acute ischemic stroke. Curr Opin Drug Discov Devel (2008) 0.87
The use of erythtropoietin in cerebral diseases. Panminerva Med (2008) 0.87
Recombinant human erythropoietin in the treatment of human brain disease: focus on cognition. J Ren Nutr (2008) 0.86
Neuroprotective properties of epoetin alfa. Nephrol Dial Transplant (2002) 0.86
Attenuation of ischemic brain edema by pentobarbital after carotid ligation in the gerbil. Stroke (1980) 0.84
Endothelin b receptor deficiency is associated with an increased rate of neuronal apoptosis in the dentate gyrus. Neuroscience (2000) 0.83
[Erythropoietin--a new therapy in cerebral ischemia?]. Ugeskr Laeger (2003) 0.81
Effect of DPPD (diphenyl-para-phenylenediamine) on stroke and cerebral edema in gerbils. Stroke (1978) 0.80
Different expression patterns of Ngb and EPOR in the cerebral cortex and hippocampus revealed distinctive therapeutic effects of intranasal delivery of Neuro-EPO for ischemic insults to the gerbil brain. J Histochem Cytochem (2011) 0.78
New targets of neuroprotection in ischemic stroke. ScientificWorldJournal (2008) 0.78
Enhancing the delivery of erythropoietin and its variants into the ischemic brain. ScientificWorldJournal (2009) 0.78
[The objective of acute stroke therapy and neuroprotective therapeutic approaches]. Rev Neurol (1999) 0.78
Locomotor activity in the ischemic gerbil. Brain Res (1993) 0.77
Don't give up on erythropoietin as a neuroprotective agent. Pediatrics (2005) 0.76
Mongolian gerbil (Meriones unguiculatus) as a model of cerebral infarction for testing new therapeutic agents. Methods Find Exp Clin Pharmacol (2000) 0.76
[Neurotoxicity, neuroprotection and therapeutic window in cerebral ischemia]. Rev Neurol (1999) 0.76
Variable response of the Mongolian gerbil to unilateral carotid occlusion: magnetic resonance imaging and neuropathological characterization. Ital J Neurol Sci (1995) 0.76
[Endogenous neuronal protection: an alternative approach]. Rev Neurol (2004) 0.76
Treatment with nasal neuro-EPO improves the neurological, cognitive, and histological state in a gerbil model of focal ischemia. ScientificWorldJournal (2010) 1.45
An epidemiological study of neuromyelitis optica in Cuba. J Neurol (2009) 1.30
Short-term prognostic value of serum neuron specific enolase and S100B in acute stroke patients. Clin Biochem (2012) 0.95
Different expression patterns of Ngb and EPOR in the cerebral cortex and hippocampus revealed distinctive therapeutic effects of intranasal delivery of Neuro-EPO for ischemic insults to the gerbil brain. J Histochem Cytochem (2011) 0.78
Association between Blood Lipids and Types of Stroke. MEDICC Rev (2008) 0.77